Debra Stuurman

Debra Stuurman is a Researcher in the Department of Radiology and Nuclear Medicine at Erasmus University Medical Center. Her work spans experimental oncology, radionuclide therapy, and the development of targeted molecular agents for cancer diagnostics and treatment.

Research Focus: Her primary interests include optimizing radionuclide therapies (e.g., Lu-177, Tb-161), investigating drug conjugates for neuroendocrine and prostate cancers, and evaluating tumor-targeting mechanisms like fibroblast activation protein (FAP) and GRPR expression. She employs preclinical models to assess biodistribution and therapeutic efficacy of novel compounds.

Publication Trends: Recent articles emphasize translational theranostics, with innovations in radioisotope applications, small-molecule drug conjugates, and imaging-guided cancer therapies. Studies frequently integrate pharmacology with nuclear medicine techniques.